Aarogyasri and PMJAY for pancreatic cancer in Telangana — what is covered, and what to check first

Most families search for Aarogyasri pancreatic cancer cover, or for whether PMJAY pancreatic cancer treatment is included, in the first day or two after a scan report — before anyone has explained the plan. That is the right instinct and it deserves a straight answer rather than a reassuring one. Eligible treatment may be largely covered at empanelled centres. What that sentence hides, and what nobody explains at the counter, is how cover is granted: part by part, against a named procedure, after approval has been raised and given — not as a sum of money handed to you to spend as the plan unfolds.

Two schemes sit behind the question. Aarogyasri is the Telangana state health scheme, linked to your household ration card and verified against your identity documents. PMJAY, the national Ayushman Bharat scheme, covers eligible households across the country. In Telangana the two are administered together, so in practice most families are assessed once at the hospital scheme desk rather than applying twice. Either way the mechanics are the same. Cover applies at hospitals that are empanelled in the network, against procedures that are on the approved list, and only once pre-authorisation has been raised for your case and approved. Somebody saying “it is covered” across a desk is not approval. The approval is a document.

There is one complication specific to this cancer, and we would rather say it plainly than let you find it out from a bill. Pancreatic care is not delivered by one team in one building. At CION, the consultation and treatment plan, tumour board review, chemotherapy, radiation, chemoradiation and SBRT, the staging scans and their reporting, CA 19-9 and bloods, genetic counselling, nutrition and pancreatic enzyme support, pain and psycho-oncology care and long-term follow-up are delivered in-house across 35+ centres in Telangana and Andhra Pradesh. The operation itself, staging laparoscopy, the endoscopic ultrasound biopsy, ERCP and biliary stenting, a coeliac plexus block for pain and PET-based scanning are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partners — performed at their unit, approved under their empanelment, and billed there. So Aarogyasri pancreatic cancer treatment is not one approval. It is a set of approvals, sought in different places, and a family that assumes otherwise finds the gap late.

The rest of this page is the practical version of that: where cover usually applies, where it usually does not, what to carry with you, and what our team does about the paperwork. If you want the clinical picture first, start with the complete guide to pancreatic cancer, or read how the pathway is organised in our overview of pancreatic cancer treatment in Hyderabad.

• The card the scheme is linked to, and your identity documents. Carry the originals along with copies for the patient and, where asked, for the household. Eligibility is established from documents, not from a conversation.
• Every scan, report, disc and prescription you already hold. Including anything from another hospital. A pre-authorisation is built on the imaging and reports, so incomplete paperwork slows the approval more often than the diagnosis does.
• Ask which specific centre you will be treated at. Networks are empanelled centre by centre. The question that matters is whether the place your treatment will physically happen is in the network, not whether the organisation is.
• Ask who raises the pre-authorisation for the coordinated parts. For the biopsy, the stent, the PET scan and the operation, the paperwork is raised by the partner hospital under its own empanelment. Ask for a named person there.
• Ask what the package does not include. Get the excluded items named while there is still time to plan for them, rather than discovering them one invoice at a time.
• If you live in Andhra Pradesh, you are on a different route. The equivalent scheme there is NTR Vaidya Seva for pancreatic cancer treatment, which works on the same principle with its own empanelment list and paperwork.
• If you also hold a policy, bring it. A private policy and a scheme are not alternatives you must choose between blindly — read insurance and cashless cover for pancreatic cancer treatment before you decide which route to use for which part.
• Do not postpone the first consultation while paperwork is sorted. The consultation is free and does not depend on any scheme. Waiting for approval before being assessed is the one delay that costs you something clinical.

Not every family is eligible, and not every part of a plan sits inside a package even when they are. That is worth saying early rather than discovering halfway through. It is also not the end of the conversation, because there is usually more than one route open at once and they can be used for different parts of the same pathway.

If you live in Andhra Pradesh rather than Telangana, the scheme you are looking for is a different one. Pancreatic cancer treatment under NTR Vaidya Seva works on the same principle — empanelled centres, approved procedures, pre-authorisation before treatment — with its own list and its own paperwork, and the same need to ask the question of each hospital in the pathway separately.

If you hold a private policy, that is a separate route with separate rules, and what decides the outcome is pre-authorisation, cashless tie-ups, waiting periods, room-rent limits and whether day-care chemotherapy is admitted without an overnight stay. The complication is the familiar one: the coordinated parts of your care usually need their own pre-authorisation raised at the partner hospital, on their letterhead. Insurance and cashless cover for pancreatic cancer treatment sets out what to check and in what order, and it is worth reading before an admission rather than during one.

And if none of these apply, say so plainly at the first visit instead of quietly postponing treatment. Sequencing is where most of the room is. Scans already done elsewhere are not repeated unless a repeat would change the answer. The parts that keep you well and on treatment — enzyme replacement, nutrition, pain control — are among the least expensive parts of the plan and among the most valuable. There is also usually more scope than families expect to have parts of the treatment given nearer home. Decisions here are made for healing, not for billing, and a family with no scheme and no policy is still owed a plan and a straight explanation of it.

1. 1

   A free 45-minute consultation, whatever your scheme status

   Long enough to go through the scans and reports properly, with a written second opinion included. Nothing about this visit depends on a card, an approval or a policy. Bring every report and disc you have, including anything from another hospital.

   In-house at CION
2. 2

   Your documents are checked, not assumed

   Eligibility is established from the card and identity documents rather than from a conversation at a counter. Where something is missing, you are told exactly what to bring rather than sent away to find out.

   In-house at CION
3. 3

   Tumour board agrees the plan before the paperwork is raised

   Medical, surgical and radiation oncologists review the case together. Raising approvals before the plan is settled is how families end up with paperwork for treatment they never have, so the sequence runs the other way round.

   In-house at CION
4. 4

   The plan is split, and the cover question is asked of each part

   You are told which parts are delivered here and which are coordinated with a partner centre. For the coordinated parts, the approval sits with that hospital, and we tell you which one and who to speak to rather than leaving you to work it out.

   In-house at CION, with the coordinated items named
5. 5

   The gaps are named before anything starts

   Whatever falls outside the approved package is written down and explained while there is still time to plan for it. If the scheme route does not open, the alternatives are put in front of you the same day, not weeks later.

   In-house at CION; coordinated approvals raised by the partner hospital

Medical disclaimer: This page explains how Aarogyasri and PMJAY cover is established for pancreatic cancer treatment and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and is not a confirmation of cover, an approval or a quotation. No cover limit, package rate or figure is stated here. Scheme eligibility, empanelment of a given centre, inclusion of a procedure in an approved package and pre-authorisation are determined by the scheme authorities and must be confirmed for your own case and for each part of your pathway. Consultation and treatment planning, tumour board, chemotherapy, radiation, chemoradiation and SBRT, staging scan ordering and reporting, CA 19-9 and bloods, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain and psycho-oncology care and survivorship follow-up are delivered by CION. All pancreatic surgery, staging laparoscopy, endoscopic ultrasound and biopsy, ERCP and biliary or duodenal stenting, coeliac plexus block, PET-CT and DOTATATE PET and PRRT are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partner centres, where approval and billing may sit with that partner hospital.